Taysha Gene Therapies(TSHA.US)

Last Updated 19:00:00 ET
longbridge loading

Taysha Gene Therapies Ramps Up Ahead of TSHA-102 BLA

Tip Ranks·
US
TSHA
+1.91%
US
PBE
+0.50%
US
IBB
+0.66%
Tip Ranks·
US
TSHA
+1.91%
US
PBE
+0.50%
US
IBB
+0.66%

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Average Recommendation of "Buy" by Brokerages

Market Beat·
US
TSHA
+1.91%
US
FBT
+0.74%
US
ARKG
+2.86%
Market Beat·
US
TSHA
+1.91%
US
FBT
+0.74%
US
ARKG
+2.86%

Taysha Gene Therapies Q1 Earnings Call Highlights

Market Beat·
US
TSHA
+1.91%
US
ARKG
+2.86%
US
IXJ
+0.59%
Market Beat·
US
TSHA
+1.91%
US
ARKG
+2.86%
US
IXJ
+0.59%

Chardan Capital Remains a Buy on Taysha Gene Therapies (TSHA)

Tip Ranks·
US
TSHA
+1.91%
US
XBI
+0.80%
US
ARKG
+2.86%
Tip Ranks·
US
TSHA
+1.91%
US
XBI
+0.80%
US
ARKG
+2.86%

Taysha Gene Therapies | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
TSHA
+1.91%
Earnings Watch·
US
TSHA
+1.91%

Taysha Gene Therapies (TSHA) to Release Earnings on Wednesday

Market Beat·
US
TSHA
+1.91%
US
PBE
+0.50%
US
ARKG
+2.86%
Market Beat·
US
TSHA
+1.91%
US
PBE
+0.50%
US
ARKG
+2.86%

Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6

Unusual Whales·
US
TSHA
+1.91%
US
XBI
+0.80%
US
FBT
+0.74%
Unusual Whales·
US
TSHA
+1.91%
US
XBI
+0.80%
US
FBT
+0.74%
© 2026 Longbridge｜Disclaimer